Skip to main content
Market intelligence
MLYSHealthcare

Mineralys Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 17, 2026David Malcom RodmanChief Medical OfficerSale14,474$24.19$350,087
Jun 17, 2026Daphne KarydasCorporate insiderSale3,000$25.00$75,000
Jun 12, 2026David Malcom RodmanChief Medical OfficerSale8,519$24.20$206,151